Zimmer Holdings (NYSE:ZMH) announced layoffs at its Warsaw, Ind., headquarters, pointing to the expected burden of the medical device tax as partly responsible for some of the losses.
The orthopedics device maker plans to offset the entire burden posed by the impending 2.3% device levy in 2013 through cost-cutting efforts, part of which include layoffs.
The home-base reshuffling is tied to a larger company-wide restructuring program aimed at finding $400 million in cost savings before 2016, prompted in part by an anticipated $60 million tax bill for 2013.
"The transformation program’s more far-reaching than just the device tax, but I think that the device tax is probably a big catalyst in the company looking at the transformation program," Zimmer spokesman Garry Clark told MassDevice.
The orthopedics device maker plans to outsource its 120-employee transportation management team to a hub in Memphis, Tenn., beginning in the 3rd quarter, and will also cut about 50 other positions globally before the end of the year, Clark said.
The company made the announcement early in order to allow some of those workers to shift to other roles, he added.
Zimmer isn’t the first to announce layoffs ahead of the tax.
Stryker announced in November that it would cut 5% of its global workforce to save $100 million dollars, the amount it expects to pay when the tax goes live next year. The Kalamazoo, Mich.-based orthopedic device giant eliminated 160 jobs in December.
Industry lobby AdvaMed estimates that the tax will result in 43,000 jobs lost in the medical device field.
Here are latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Pathfinder names former Medtronic GM Jim Cloar president & CEO
Pathfinder Therapeutics, maker of "surgical GPS" products for the abdomen, named Jim Cloar president & CEO. Cloar was formerly general manager of the imaging division for Medtronic (NYSE:MDT). Read more
- Angeion names Wendy Lynch, co-director of Alatrum Institute’s Center for Consumer Choice, to board of directors
- pSivida adds HeartWare International CEO Douglas Godshall to board
- Neurotech announces new territory manager for Minnesota and Western Wisconsin
These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.
View Technology Track Featured Sessions
Register today to save. Use code TECHTRACK to save an additional 10%.